Three-dimensional printing of tricalcium silicate/mesoporous bioactive glass cement scaffolds for bone regeneration

2016 ◽  
Vol 4 (46) ◽  
pp. 7452-7463 ◽  
Author(s):  
Peng Pei ◽  
Xin Qi ◽  
Xiaoyu Du ◽  
Min Zhu ◽  
Shichang Zhao ◽  
...  

Tricalcium silicate/mesoporous bioactive glass (C3S/MBG) cement scaffolds were successfully fabricated for the first time by 3D printing with a curing process, which combined the hydraulicity of C3S with the excellent biological property of MBG together.

2014 ◽  
Vol 10 (5) ◽  
pp. 2269-2281 ◽  
Author(s):  
Jianhua Zhang ◽  
Shichang Zhao ◽  
Yufang Zhu ◽  
Yinjun Huang ◽  
Min Zhu ◽  
...  

Pharmaceutics ◽  
2019 ◽  
Vol 11 (6) ◽  
pp. 274 ◽  
Author(s):  
Pamela Robles-Martinez ◽  
Xiaoyan Xu ◽  
Sarah J. Trenfield ◽  
Atheer Awad ◽  
Alvaro Goyanes ◽  
...  

Three-dimensional printing (3DP) has demonstrated great potential for multi-material fabrication because of its capability for printing bespoke and spatially separated material conformations. Such a concept could revolutionise the pharmaceutical industry, enabling the production of personalised, multi-layered drug products on demand. Here, we developed a novel stereolithographic (SLA) 3D printing method that, for the first time, can be used to fabricate multi-layer constructs (polypills) with variable drug content and/or shape. Using this technique, six drugs, including paracetamol, caffeine, naproxen, chloramphenicol, prednisolone and aspirin, were printed with different geometries and material compositions. Drug distribution was visualised using Raman microscopy, which showed that whilst separate layers were successfully printed, several of the drugs diffused across the layers depending on their amorphous or crystalline phase. The printed constructs demonstrated excellent physical properties and the different material inclusions enabled distinct drug release profiles of the six actives within dissolution tests. For the first time, this paper demonstrates the feasibility of SLA printing as an innovative platform for multi-drug therapy production, facilitating a new era of personalised polypills.


Author(s):  
K. G. Siree ◽  
T. M. Amulya ◽  
T. M. Pramod Kumar ◽  
S. Sowmya ◽  
K. Divith ◽  
...  

Three-dimensional (3D) printing is a unique technique that allows for a high degree of customisation in pharmacy, dentistry and in designing of medical devices. 3D printing satiates the increasing exigency for consumer personalisation in these fields as custom-made medicines catering to the patients’ requirements are novel advancements in drug therapy. Current research in 3D printing indicates towards reproducing an organ in the form of a chip; paving the way for more studies and opportunities to perfecting the existing technique. In addition, we will also attempt to shed light on the impact of 3D printing in the COVID-19 pandemic.


2016 ◽  
Author(s):  
Hongxing Luo ◽  
Zhongmin Wang

We comment on the recent developments and problems of three-dimensional printing in cardiology. Since there are currently no standards or consensuses for 3D printing in clinical medicine and the technology is at its infancy in cardiology, it’s very important to detail the procedures to allow more similar studies to further our understandings of this novel technology. Most studies have employed computed tomography to obtain source data for 3D printing, the use of real-time 3D transesophageal echocardiography for data acquisition remains rare, so it would be very valuable and inspiring to detail the image postprocessing steps, or the reliability of the study results will be doubtful.


2020 ◽  
Vol 2020 ◽  
pp. 1-6 ◽  
Author(s):  
Marcin Metlerski ◽  
Katarzyna Grocholewicz ◽  
Aleksandra Jaroń ◽  
Mariusz Lipski ◽  
Grzegorz Trybek ◽  
...  

Three-dimensional printing is a rapidly developing area of technology and manufacturing in the field of oral surgery. The aim of this study was comparison of presurgical models made by two different types of three-dimensional (3D) printing technology. Digital reference models were printed 10 times using fused deposition modelling (FDM) and digital light processing (DLP) techniques. All 3D printed models were scanned using a technical scanner. The trueness, linear measurements, and printing time were evaluated. The diagnostic models were compared with the reference models using linear and mean deviation for trueness measurements with computer software. Paired t-tests were performed to compare the two types of 3D printing technology. A P value < 0.05 was considered statistically significant. For FDM printing, all average distances between the reference points were smaller than the corresponding distances measured on the reference model. For the DLP models, the average distances in the three measurements were smaller than the original. Only one average distance measurement was greater. The mean deviation for trueness was 0.1775 mm for the FDM group and 0.0861 mm for the DLP group. Mean printing time for a single model was 517.6 minutes in FDM technology and 285.3 minutes in DLP. This study confirms that presurgical models manufactured with FDM and DLP technologies are usable in oral surgery. Our findings will facilitate clinical decision-making regarding the best 3D printing technology to use when planning a surgical procedure.


2013 ◽  
Vol 397-400 ◽  
pp. 970-980 ◽  
Author(s):  
Noor A. Ahmed ◽  
J.R. Page

The phenomenal growth in three-dimensional printing technology has the potential of ushering in the next wave of industrial revolution. As part of an advanced project design conducted at the Aerospace Engineering of the University of New South, the concept of a printable unmanned aerial vehicle was explored. A subsequent small scale test model was manufactured using three-dimensional printing technology for wind tunnel testing and validation. The exercise demonstrates the huge potential of such printing technology in future aircraft designs.Key words: 3D printing, design, manufacture, UAV


2021 ◽  
Vol 926 (1) ◽  
pp. 012080
Author(s):  
C Amni ◽  
Marwan ◽  
S Aprilia ◽  
E Indarti

Abstract Three-dimensional printing (3DP) provides a fast and easy fabrication process without demanding post-processing. 3D-bioprinting is a special class in 3DP. Bio-printing is the process of accurately 3DP structural design using filament. 3D bio-printing technology is still in the development stage, its application in various engineering continues to increase, such as in tissue engineering. As a forming material in 3D printing, many types of commercial filaments have been developed. Filaments can be produced from either natural or synthetic biomaterials alone, or a combination of the two as a hybrid material. The ideal filament must have precise mechanical, rheological and biological properties. Polycaprolactone (PCL) is specifically developed and optimized for bio-printing of 3D structures. PCL is a strategy in 3D printing to better control interconnectivity and porosity spatially. Structural stability and less sensitive properties environmental conditions, such as temperature, humidity, etc make PCL as an ideal material for the FDM fabrication process. In this review, we provide an in-depth discussion of current research on PCL as a filament currently used for 3D bio-printing and outline some future perspectives in their further development.


Sign in / Sign up

Export Citation Format

Share Document